PlainRecalls
FDA Drug Moderate Class II Ongoing

Ketorolac Tromethamine Ophthalmic Solution, 0.5%, 5 mL, Rx Only, Sterile, Manufactured by: Apotex Inc., Richmond Hill, Ontario, Canada, L4C 5H2, Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-1003-1.

Reported: October 8, 2025 Initiated: September 5, 2025 #D-0677-2025

Product Description

Ketorolac Tromethamine Ophthalmic Solution, 0.5%, 5 mL, Rx Only, Sterile, Manufactured by: Apotex Inc., Richmond Hill, Ontario, Canada, L4C 5H2, Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-1003-1.

Reason for Recall

Lack of Assurance of Sterility; atypical weight loss due to improper bottle sealing leading to potential sterility concerns

Details

Recalling Firm
Apotex Corp.
Units Affected
493,468 bottles
Distribution
Nationwide in the US
Location
Weston, FL

Frequently Asked Questions

What product was recalled?
Ketorolac Tromethamine Ophthalmic Solution, 0.5%, 5 mL, Rx Only, Sterile, Manufactured by: Apotex Inc., Richmond Hill, Ontario, Canada, L4C 5H2, Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-1003-1.. Recalled by Apotex Corp.. Units affected: 493,468 bottles.
Why was this product recalled?
Lack of Assurance of Sterility; atypical weight loss due to improper bottle sealing leading to potential sterility concerns
Which agency issued this recall?
This recall was issued by the FDA Drug on October 8, 2025. Severity: Moderate. Recall number: D-0677-2025.